Navigation Links
Global Biomarkers Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Date:10/20/2013

Albany, New York, USA (PRWEB) October 20, 2013

A biomarker is a gene, molecule or characteristics, by which pathogenic processes, biological processes or pharmacologic response can be evaluated or measured. They are classified on the basis of their application in different medical processes. These biomarkers help effectively in clinical decision making and thus help in diagnosing the health of a patient. In the present scenario, biomarkers are extensively used in the treatment of diseases such as cancer.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/biomarkers-market.html.

The worldwide market of biomarkers is increasing tremendously due to its popularity and wide use in different drug discovery. Its extensive use in medical areas such as research and cancer treatment is highly increasing its demand. Several new companies are entering the biomarker market and new acquisitions and mergers are further supporting the growth of this market.

The global biomarker market was worth USD 13.16 in 2011 and it is expected to reach USD 34 billion by 2018, growing at a CAGR of 14.70% from 2011 to 2018. As of now, oncology earned the highest revenue but cardiology is expected to grow at a faster rate at a CAGR of 16.32% from 2011 to 2018. North America is noticed as the fastest growing region due to high adoption rate of high throughput technologies used in biomarker discovery, wide use of biomarkers in cancer treatment and rapid growth of IT industry in that region.

The new product launches, emergence of new players in the market and several mergers, acquisitions and joint ventures serve as a major driver for the growth of the biomarkers market. Major players in the biomarkers market are Abbott Laboratories, Agilent Technologies Inc., Affymetrix Inc., Becton, Dickinson and Company, Celera Corporation, Bruker Corporation,DiagnoCure Inc., Epigenomics AG, Clarient Inc., and GE Healthcare among others.

Related Report : Cancer Biomarkers Market
http://www.transparencymarketresearch.com/cancer-biomarkers-market.html

Reasons for Buying this Report

-This report provides pin-point analysis for changing competitive dynamics
-It provides a forward looking perspective on different factors driving or restraining market growth
-It provides a technological growth map over time to understand the industry growth rate
-It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
-It helps in understanding the key product segments and their future
-It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
-It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
-It provides distinctive graphics and exemplified SWOT analysis of major market segments

Browse Blog: http://udallas.academia.edu/transparencymarketresearch/
Browse all Market Research reports: http://www.transparencymarketresearch.com

Read the full story at http://www.prweb.com/releases/2013/10/prweb11246531.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Cardiac Prosthetic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
2. It Works! Global Restocks the Shelves of the Salvation Army
3. Texas A&M Advances Global Disease Prevention with Launch of Field-to-Clinic Initiative
4. República’s Jorge A. Plasencia and Luis Casamayor Recognized as Global Agency Innovators by The Internationalist Magazine
5. LDM Global eDiscovery Professional, Jennifer Holt, is Awarded CEDS Certification
6. RAPS Releases New Edition of Unique Global Regulatory Affairs Reference Book
7. Global Breast Pumps Industry – New Research Available
8. Global Metal Packaging Industry
9. Vitamin D3 Market in China and Global Regions 2013 Structure and Value Analysis in a New Research Study at DeepResearchReports.com
10. Operation Smile’s 2013 Smile Gala and Global Summit Celebrates 30 Years of Successes
11. Global Medical Imaging Reagents Market 2016 Forecast Report Now Available at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... VeloReality President ... next generation LYNX VR Indoor Trainer with multi-rider capability to an enthusiastic audience ... not only reduce the weight of the unit, they also enhance the rider's ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco Canales, MD and Heather ... Napa Valley office. The technique utilizes the body’s own healing abilities to quickly ... Furnas, are part of only a select few cosmetic surgeons bringing this procedure ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official ... NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in ... from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are ...
(Date:2/5/2016)... ... ... Boar’s Head Brand®, one of the nation’s leading providers of premium delicatessen foods, ... out of your party preparation – follow these easy, yet delicious recipes with the ... , “The key to hosting a successful game-day party is creating a flavorful menu ...
(Date:2/5/2016)... Francisco, CA (PRWEB) , ... February 05, 2016 ... ... and founder of CitiDent, announces that it is now welcoming orthodontist, ... Dr. Cheng, CitiDent offers a complete range of oral health care, including general ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... -- Mettler-Toledo International Inc. (NYSE: MTD ) today ... the highlights: , Sales in local currency ... year.  Reported sales decreased 3% as currency reduced sales ... earnings per diluted share as reported (EPS) were $4.44, ... EPS was $4.65, an increase of 10% over the ...
(Date:2/4/2016)... -- In response to the opioid abuse epidemic, today Dr. ... Products and Tobacco, along with other FDA leaders, called for ... opioid medications. The plan will focus on policies aimed at ... to effective relief. --> ... risk-benefit paradigm for opioids and ensure that the agency considers ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: